Phathom Pharmaceuticals (PHAT)
(Delayed Data from NSDQ)
$11.75 USD
0.00 (0.00%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $11.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -1.30 |
EPS Last Quarter | -1.25 |
Last EPS Surprise | -4.17% |
ABR | 1.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.80 |
Next Year | -4.07 |
EPS (TTM) | -4.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.94M | 21.98M | 40.48M | 136.22M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 13.04M | 23.08M | 42.96M | 167.76M |
Low Estimate | 8.41M | 21.28M | 35.81M | 119.73M |
Year ago Sales | 0.00M | 0.68M | 0.68M | 40.48M |
Year over Year Growth Est. | NA | 3,132.79% | 5,836.01% | 236.49% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.30 | -1.19 | -4.80 | -4.07 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -1.22 | -1.08 | -4.68 | -3.86 |
Low Estimate | -1.38 | -1.30 | -4.91 | -4.27 |
Year ago EPS | -0.76 | -0.80 | -2.53 | -4.80 |
Year over Year Growth Est. | -71.05% | -48.75% | -89.72% | 15.21% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.30 | -1.19 | -4.80 | -4.07 |
7 Days Ago | -1.30 | -1.19 | -4.80 | -4.07 |
30 Days Ago | -1.30 | -1.19 | -4.80 | -4.07 |
60 Days Ago | -1.30 | -1.19 | -4.80 | -4.07 |
90 Days Ago | -1.21 | -1.09 | -4.57 | -3.85 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.30 | -1.19 | -4.80 | -4.07 |
Zacks Consensus Estimate | -1.30 | -1.19 | -4.80 | -4.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.25 | -1.42 | -0.80 | -0.76 | NA |
Estimate | -1.20 | -1.43 | -0.92 | -0.95 | NA |
Difference | -0.05 | 0.01 | 0.12 | 0.19 | 0.07 |
Surprise | -4.17% | 0.70% | 13.04% | 20.00% | 7.39% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more